Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. L. Dente, E. Garbella, E. Bacci, S. Cianchetti, A. DiFranco, E. Masino, P. Paggiaro (Pisa, Italy). Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics. Eur Respir J 2006; 28: Suppl. 50, 744

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic inflammation in sputum of poorly controlled asthmatics Source: Eur Respir J 2002; 20: 1370-1377 Year: 2002 Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004 Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003 Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002 Inflammatory subtypes in cough variant asthma (CVA): assessment using induced sputum Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Inflammatory cell activation in eosinophilic and non-eosinophilic asthma Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response Source: Eur Respir J 2003; 22: 118-126 Year: 2003 Noninvasive assessment of inflammation in severe asthma Source: Eur Respir Mon 2011; 51: 208-217 Year: 2011 Conclusion: clinical phenotypes of asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010